In this situation, combinatory analysis of CSF α-synuclein and/or DJ-1 with other PD biomarkers, such as oxidative stress-related molecules, pro-inflammatory factors and some growth factors, might be effective. This evidence concerns the gene SNCA and Parkinson disease.